HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Ralf Sodian Roland Hetzer Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Potapov, E. V. Articles by Hetzer, R. Search for Related Content PubMed PubMed Citation Articles by Potapov, E. V. Articles by Hetzer, R. Related Collections Extracorporeal circulation

Ann Thorac Surg 2002;74:384-389
© 2002 The Society of Thoracic Surgeons

---

Original article: cardiovascular

Impact of cardiac surgery using cardiopulmonary bypass on course of chronic lymphatic leukemia: a case-control study

^a Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum Berlin, Germany
^b Department of Hematology and Oncology, Humboldt University of Berlin, Charité, Campus Virchow Klinikum, Berlin, Germany

Accepted for publication April 10, 2002.

* Address reprint requests to Dr Potapov, Deutsches Herzzentrum Berlin, Augustenburger Platz 1, 13353 Berlin, Germany
e-mail: potapov{at}dhzb.de

Background. Chronic lymphatic leukemia (CLL) is a common disease among elderly individuals. The number of older patients undergoing operations with cardiopulmonary bypass (CPB) is increasing. The aim of the present study was to evaluate the impact of cardiac surgery using CPB on the long-term course of CLL.

Methods. From 1992 to 2000, a total of 28 patients with CLL underwent heart surgery using CPB at our institution (group I). These patients were compared with 25 patients from the CLL register who were retrospectively matched with regard to preoperative administration of chemotherapy, Binet classification, age, and sex (group II). A time-point was selected for each patient in group II so that the variables for the two groups corresponded in relation to the time of operation of the patients in group I. Midterm follow-up data in both groups were analyzed.

Results. There were no differences between groups regarding matched variables. The mean follow-up time was similar in both groups (2.6 ± 2.2 vs 2.3 ± 1.3 years, p > 0.5). The 30-day mortality in group I was 14.3%. The mean stay in the intensive care unit was 4.2 ± 7.5 days; the median number of units of packed red blood cells transfused was three (range 0 to 17). Compared with group II, in group I significantly fewer patients (11 vs 17, p = 0.049) required chemotherapy significantly later (1.98 ± 2.06 vs 0.84 ± 1.18 years, p = 0.018). During follow-up, no difference was found between groups regarding severe infections (10 vs 14, p = 0.14). Despite postoperative mortality in group I, the long-term mortality was similar in both groups (p = 0.3).

Conclusions. Cardiac surgery using CPB did not have a negative impact on the natural course of CLL. Moreover, this procedure seems to be associated with a decrease in the number of postoperative chemotherapy administrations and with an increase of chemotherapy-free survival time. Although CLL may be a risk factor in the early postoperative period, it is not a contraindication for cardiac surgery using CPB.

This article has been cited by other articles:

				A. M. Fecher, T. J. Birdas, D. Haybron, P. K. Papasavas, D. Evers, and P. F. Caushaj Cardiac operations in patients with hematologic malignancies Eur. J. Cardiothorac. Surg., April 1, 2004; 25(4): 537 - 540. [Abstract] [Full Text] [PDF]